Colorectal Cancer
Copyright ©2007 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Feb 21, 2007; 13(7): 1018-1026
Published online Feb 21, 2007. doi: 10.3748/wjg.v13.i7.1018
Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition
Jie Cao, Xiao-Ping Chen, Wang-Lin Li, Jie Xia, Hong Du, Wei-Biao Tang, Hui Wang, Xi-Wen Chen, Huan-Qing Xiao, Yu-Yuan Li
Jie Cao, Wang-Lin Li, Jie Xia, Wei-Biao Tang, Hui Wang, Xi-Wen Chen, Huan-Qing Xiao, Department of Gastrointestinal Surgery, Affiliated Guangzhou First People’s Hospital, Guangzhou Medical College, Guangzhou 510180, Guangdong Province, China
Xiao-Ping Chen, Center of Hepatic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China
Hong Du, Department of Pathology, Affiliated Guangzhou First People’s Hospital, Guangzhou Medical College, Guangzhou 510180, Guangdong Province, China
Yu-Yuan Li, Department of Gastroenterology, Affiliated Guangzhou First People’s Hospital, Guangzhou Medical College, Guangzhou 510180, Guangdong Province, China
Author contributions: All authors contributed equally to the work.
Supported by the Natural Science Foundation of Guangdong Province, No. 06020005
Correspondence to: Jie Cao, MD, Department of Gastrointestinal Surgery, Affiliated Guangzhou First People’s Hospital, Guangzhou Medical College, 1# Pang Fu Road, Guangzhou 510180, Guangdong Province, China. czhongt@126.com
Telephone: +86-20-81048185 Fax: +86-20-81045937
Received: November 14, 2006
Revised: December 3, 2006
Accepted: January 18, 2007
Published online: February 21, 2007
Abstract

AIM: To detect the expression of fragile histidine triad (FHIT) in normal colorectal tissue, colorectal adenoma and colorectal cancer (CRC) tissue, and to analyze its relationship with the clinicopathological features of CRC, and apoptosis-associated proteins (Bcl-2, Bax, survivin) and apoptosis in colorectal cancer.

METHODS: FHIT mRNA analysis was performed by nested reverse transcription-polymerase chain reaction (RT-PCR) assay. Tissue microarray (TMA) was established to detect the expression of FHIT, Bcl-2, Bax and survivin genes in 80 CRC tissue specimens, 16 colorectal adenoma tissue specimens and 16 hemorrhoid (PPH) tissue specimens during the same period of time as the control. Citrate-microwave-SP was used as immunohistochemical method. The relationship between clinicopathological factors, such as differentiation grades and 5-year survival rate was observed. TUNEL assay was used to detect the apoptosis index in 80 CRC tissue specimens.

RESULTS: Ten out of 26 (38.5%) CRC tissue specimens expressed aberrant FHIT transcripts, none of the aberrant FHIT transcripts was observed in the matched normal tissue and colorectal adenoma tissue by nested RT-PCR assay. The positive rate of FHIT gene expression in normal colorectal tissue, colorectal adenoma and carcinoma tissue was 93.75%, 68.75% and 46.25%, respectively. Clinicopathological analysis of patients showed that the decreased FHIT gene expression was not associated with age, sex, serum CEA levels, tumor site and size, histological classification. However, the expression of FHIT was correlated with differentiation grades, pathological stages, lymph node metastases and 5-year survival rate after operation. The positive rate of apoptosis-associated proteins (Bax, Bcl-2 and survivin) in CRC tissue was 72.50%, 51.25% and 77.50%, respectively. The expression of these apoptosis-associated proteins in CRC tissue was correlated with the expression of FHIT. The mean apoptosis index in FHIT negative tumors was significantly lower than that in FHIT positive tumors (5.41 ± 0.23 vs 0.56 ± 0.10, P < 0.01).

CONCLUSION: The FHIT gene plays an important role in the regulation of apoptosis and decreased FHIT expression plays a key role in the initiation and progression of colorectal carcinoma.

Keywords: Colorectal cancer; Fragile histidine triad; Expression; Apoptosis